Literature DB >> 8589726

Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin.

F F Chehab1, M E Lim, R Lu.   

Abstract

The sterility of male and female homozygous ob/ob mice is a recognized feature of the ob mutation (1). Whereas ob/ob males can occasionally reproduce if maintained on a restricted diet, ob/ob females are always sterile (2). Thinning of the ob/ob females to normal weight by diet-restriction failed to correct their sterility. Early sexual development is normal in ob/ob females; however, ovulation never follows and the mice remain prepuberal indefinitely with no occurrence of oestrus cycles. Reproductive hormones are reduced in ob/ob females (3) demonstrating a functional defect from the hypothalamic-pituitary axis (4-6). The ovaries of ob/ob females are capable of producing viable eggs when transplanted into lean female recipients (7). Reconstitution of reproductive functions in the ob/ob female necessitates delivery of hypothalamic extracts to the third ventricle (8) and administration of pituitary extract (9), gonadotropic hormones (10), progesterone (11) and relaxin (12). These previous findings demonstrate that the sterility of ob/ob females is caused by an insufficiency of hormones at the hypothalamic-pituitary level rather than physical hindrance of copulatory activity, pregnancy and parturition caused by excess adipose tissue. We show here that repeated administration of only the recombinant human ob protein, leptin, into homozygous female ob/ob mice can correct their sterility, thus resulting in ovulation, pregnancy and parturition.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8589726     DOI: 10.1038/ng0396-318

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  254 in total

1.  Leptin and puberty.

Authors:  P E Clayton; J A Trueman
Journal:  Arch Dis Child       Date:  2000-07       Impact factor: 3.791

2.  Haploinsufficiency of the melanocortin-4 receptor: part of a thrifty genotype?

Authors:  R D Cone
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

Review 3.  The ovarian androgen-producing cells: a 2001 perspective.

Authors:  Denis A Magoffin
Journal:  Rev Endocr Metab Disord       Date:  2002-01       Impact factor: 6.514

4.  Leptin is not the critical signal for kisspeptin or luteinising hormone restoration during exit from negative energy balance.

Authors:  C True; M A Kirigiti; P Kievit; K L Grove; M S Smith
Journal:  J Neuroendocrinol       Date:  2011-11       Impact factor: 3.627

5.  Insufficient Angiogenesis: Cause of Abnormally Thin Endometrium in Subfertile Patients?

Authors:  Joachim Alfer; Lars Happel; Ralf Dittrich; Matthias W Beckmann; Arndt Hartmann; Andreas Gaumann; Volker U Buck; Irmgard Classen-Linke
Journal:  Geburtshilfe Frauenheilkd       Date:  2017-07-17       Impact factor: 2.915

6.  Leptin indirectly regulates gonadotropin-releasing hormone neuronal function.

Authors:  Janette H Quennell; Alicia C Mulligan; Alexander Tups; Xinhuai Liu; Sarah J Phipps; Christopher J Kemp; Allan E Herbison; David R Grattan; Greg M Anderson
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

Review 7.  A review of rodent models of type 2 diabetic skeletal fragility.

Authors:  Roberto J Fajardo; Lamya Karim; Virginia I Calley; Mary L Bouxsein
Journal:  J Bone Miner Res       Date:  2014       Impact factor: 6.741

8.  THE ENDOCRINOPATHIES OF MALE ANOREXIA NERVOSA: CASE SERIES.

Authors:  Aren Skolnick; Rifka C Schulman; Rodolfo J Galindo; Jeffrey I Mechanick
Journal:  AACE Clin Case Rep       Date:  2016

9.  Leptin signaling and Alzheimer's disease.

Authors:  Gurdeep Marwarha; Othman Ghribi
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

10.  Systemic leptin dose-dependently increases STAT3 phosphorylation within hypothalamic and hindbrain nuclei.

Authors:  James W Maniscalco; Linda Rinaman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-02-12       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.